Targeting Mitochondria to Revive Dysfunctional Regulatory T Cells

Area of Science:

• Immunometabolism
• T cell biology
• HIV research

Background:

• T cell dysfunction is a hallmark of chronic infections like HIV.
• Regulatory T cells (Tregs) play a crucial role in immune homeostasis.
• Impaired immune restoration despite antiretroviral therapy (ART) is observed in some HIV patients.

Purpose of the Study:

• To investigate the immunometabolic status of Tregs in HIV patients with suboptimal immune restoration.
• To identify potential therapeutic targets for restoring Treg function in HIV.

Main Methods:

• Analysis of mitochondrial fitness in CD4+ T cells (Tregs) from HIV patients on ART.
• Assessment of Treg function and metabolic parameters.
• In vitro studies using Interleukin-15 (IL-15) to evaluate its effect on Treg mitochondrial fitness.

Main Results:

• Patients with HIV and failed immune restoration on ART exhibited reduced mitochondrial fitness in their Tregs.
• This mitochondrial defect in Tregs was associated with T cell dysfunction.
• Treatment with IL-15 reversed the reduced mitochondrial fitness in Tregs, indicating improved mitochondrial function.

Conclusions:

• Reduced mitochondrial fitness in Tregs contributes to immune dysfunction in HIV patients undergoing ART.
• IL-15 represents a promising therapeutic target for restoring Treg function and improving immune restoration in HIV.
• Targeting immunometabolism offers a novel strategy for treating chronic infections.